4.57
前日終値:
$4.71
開ける:
$4.9
24時間の取引高:
833.48K
Relative Volume:
0.74
時価総額:
$290.48M
収益:
$157.08M
当期純損益:
$-70.36M
株価収益率:
-4.1112
EPS:
-1.1116
ネットキャッシュフロー:
$-71.69M
1週間 パフォーマンス:
-5.97%
1か月 パフォーマンス:
+16.88%
6か月 パフォーマンス:
+168.82%
1年 パフォーマンス:
+213.01%
Macrogenics Inc Stock (MGNX) Company Profile
名前
Macrogenics Inc
セクター
電話
301-251-5172
住所
9704 MEDICAL CENTER DRIVE, Rockville, MD
Compare MGNX vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
MGNX
Macrogenics Inc
|
4.57 | 293.66M | 157.08M | -70.36M | -71.69M | -1.1116 |
|
VRTX
Vertex Pharmaceuticals Inc
|
529.59 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
649.81 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
916.80 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
|
RVMD
Revolution Medicines Inc
|
189.99 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Macrogenics Inc Stock (MGNX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-10 | アップグレード | B. Riley Securities | Neutral → Buy |
| 2025-09-17 | 再開されました | Barclays | Overweight |
| 2024-11-07 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-01 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-07-31 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2024-07-31 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-05-10 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2024-05-10 | ダウングレード | Stifel | Buy → Hold |
| 2024-05-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-04-26 | 開始されました | B. Riley Securities | Buy |
| 2024-04-09 | アップグレード | TD Cowen | Hold → Buy |
| 2024-03-04 | 繰り返されました | BTIG Research | Buy |
| 2024-02-14 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-12-20 | アップグレード | Citigroup | Neutral → Buy |
| 2023-11-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2023-03-17 | ダウングレード | Guggenheim | Buy → Neutral |
| 2022-11-22 | ダウングレード | Cowen | Outperform → Market Perform |
| 2022-11-14 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2022-07-18 | ダウングレード | SMBC Nikko | Outperform → Neutral |
| 2022-07-11 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2022-05-04 | ダウングレード | Guggenheim | Buy → Neutral |
| 2022-02-28 | アップグレード | Citigroup | Neutral → Buy |
| 2022-02-11 | 開始されました | BMO Capital Markets | Outperform |
| 2022-02-04 | 開始されました | SMBC Nikko | Outperform |
| 2021-11-17 | 再開されました | Guggenheim | Buy |
| 2021-10-19 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-10-15 | 再開されました | BTIG Research | Buy |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-03-12 | アップグレード | Barclays | Underweight → Overweight |
| 2020-12-22 | 再開されました | H.C. Wainwright | Buy |
| 2020-08-03 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-06-01 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-05-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-04 | 開始されました | Barclays | Underweight |
| 2019-12-19 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-12-18 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-11-21 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2019-11-20 | 再開されました | Guggenheim | Neutral |
| 2019-05-03 | アップグレード | Wedbush | Neutral → Outperform |
| 2019-04-12 | 開始されました | Guggenheim | Neutral |
| 2019-02-07 | アップグレード | Citigroup | Sell → Buy |
| 2019-02-07 | ダウングレード | Wedbush | Outperform → Neutral |
| 2019-02-06 | アップグレード | Raymond James | Underperform → Mkt Perform |
| 2019-02-04 | ダウングレード | Citigroup | Neutral → Sell |
| 2018-12-10 | ダウングレード | Raymond James | Outperform → Underperform |
| 2018-09-10 | 再開されました | BTIG Research | Buy |
| 2018-05-31 | 開始されました | Evercore ISI | Outperform |
| 2018-03-05 | 開始されました | H.C. Wainwright | Buy |
| 2017-03-31 | 開始されました | Raymond James | Outperform |
すべてを表示
Macrogenics Inc (MGNX) 最新ニュース
MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 2500 Growth Benchmark - marketscreener.com
MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 2000 Value Benchmark - marketscreener.com
MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 2000 Growth Benchmark - marketscreener.com
MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 3000E Index - marketscreener.com
Enterprise value to revenue forward of MacroGenics, Inc. – NASDAQ:MGNX - TradingView
MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 3000E Value Benchmark - marketscreener.com
Price to earnings forward of MacroGenics, Inc. – NASDAQ:MGNX - TradingView
Enterprise value to revenue forward of MacroGenics, Inc. – BOATS:MGNX - TradingView
Enterprise value to EBITDA forward of MacroGenics, Inc. – BOATS:MGNX - TradingView
Enterprise value to EBIT forward of MacroGenics, Inc. – NASDAQ:MGNX - TradingView
Enterprise value to EBIT forward of MacroGenics, Inc. – BOATS:MGNX - TradingView
Price to sales forward of MacroGenics, Inc. – NASDAQ:MGNX - TradingView
Price to book forward of MacroGenics, Inc. – BOATS:MGNX - TradingView
MGNX Forecast — Price Target — Prediction for 2027 - TradingView
MacroGenics, Inc. Actuals & Estimates (NASDAQ:MGNX) - TradingView
M55 Forecast — Price Target — Prediction for 2027 - TradingView
A1W6ND Forecast — Price Target — Prediction for 2027 - TradingView
MacroGenics Inc (MGNX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MacroGenics: 'Hold' Potential Best-In-Class B7-H3 ADC And TZIELD Payment (NASDAQ:MGNX) - Seeking Alpha
MacroGenics To Receive $24.5 Million Milestone From Sanofi For TZIELD Approval - Pulse 2.0
MacroGenics stock rises on $24.5M Sanofi milestone payment - Investing.com
MacroGenics to receive $24.5M milestone from Sanofi on FDA approval - Investing.com Australia
MacroGenics stock rises on $24.5M Sanofi milestone payment By Investing.com - Investing.com Nigeria
Sanofi (SNY) Drives $24.5M Milestone Payment to MacroGenics - GuruFocus
MacroGenics to Receive $24.5 Million in Regulatory Milestone Payment - marketscreener.com
MacroGenics to Receive $24.5 Million Milestone Payment Following FDA Accelerated Approval of Sanofi’s TZIELD for Children with Stage 3 Type 1 Diabetes - Quiver Quantitative
Sanofi’s TZIELD approval triggers $24.5M payment to MacroGenics - Stock Titan
MacroGenics (MGNX) Gains 4.3% as Shares Test Key Resistance LevelsOrder Block - dars.gov.et
MacroGenics Inc (MGNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MacroGenics StockThursday technical snapshot after strong year-to-date rebound - AD HOC NEWS
MacroGenics Inc (MGNX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MacroGenics Inc (MGNX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MacroGenics Inc (MGNX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MacroGenics Inc (MGNX) Institutional Confidence - TradingKey
MacroGenics Inc (MGNX) Valuation: PE, PB & Fair Value Analysis - TradingKey
MacroGenics Inc (MGNX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MacroGenics Inc Stock (US5562221046): Valuation metrics in focus after recent biotech swing - Ad-hoc-news.de
How The MacroGenics (MGNX) Story Is Shifting With ADC Pipeline Bets And 2026 Data Risks - Yahoo Finance
Millennium Group and Israel Englander report 3.44M MGNX shares (5.4%) - Stock Titan
MacroGenics eyes $200M cash boost, 2028 runway ahead of cancer pipeline updates - MSN
MacroGenics (MGNX) Slips 1.19% as Biotech Stock Tests Key SupportPoint of Control - Město Břeclav
MacroGenics expands ZYNYZ royalty deal with Sagard, secures $60M upfront - MSN
MacroGenics Inc stock (US5562221046): shares ease after strong year-to-date run amid biotech volatil - AD HOC NEWS
Will MacroGenics (MGNX) report negative Q1 earnings? What you should know - MSN
Macrogenics(MGNX) Stock Options Chain | Quotes & News - Moomoo
MacroGenics, Inc. (MGNX) Latest Stock News & Headlines - Yahoo Finance
MacroGenics Eyes $200M Cash Boost, 2028 Runway Ahead of Cancer Pipeline Updates - TradingView
MGNXMacrogenics Inc Stock Price and Quote - Finviz
MacroGenics, Inc. Hits New 52-Week High of $4.64 - Markets Mojo
MacroGenics to sell manufacturing operations to Bora for $122.5M - MSN
Macrogenics Inc (MGNX) 財務データ
収益
当期純利益
現金流量
EPS
Macrogenics Inc (MGNX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| HEIDEN WILLIAM K | Director |
Aug 19 '25 |
Buy |
1.52 |
50,500 |
76,760 |
61,500 |
| HEIDEN WILLIAM K | Director |
Aug 20 '25 |
Buy |
1.49 |
49,500 |
73,755 |
111,000 |
| Koenig Scott | Director |
Aug 13 '25 |
Option Exercise |
0.00 |
52,829 |
0 |
830,244 |
大文字化:
|
ボリューム (24 時間):